logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Ryota Hase

Nagoya City University
H指数:19
被引数:1,139

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan

难治性耐药（DTR）、治疗及结果：日本IMP型碳青霉烯酶占主导的碳青霉烯耐药肠杆菌科细菌感染

Microbiology Spectrum
IF3.8
2026-06-020
PRE
Ohyama, Koji; Uemura, Kohei; Matsumura, Yasufumi; Hase, Ryota; Kato, Hideaki; Matono, Takashi; Itoh, Naoya; Hashimoto, Takehiro; Yamamoto, Go; Mawatari, Momoko; Tsutsumi, Takeya; Suzuki, Tetsuya; Suzuki, Masahiro; Hosoda, Takuya; Sakurai, Aki; Asai, Yusuke; Tsuzuki, Shinya; Hayakawa, Kayoko; van Duin, David; Ohmagari, Norio; Doi, Yohei; Saito, Sho
Development of machine-learning models to diagnose influenza among international travellers based on symptoms and epidemiological information

基于症状和流行病学信息，开发用于诊断国际旅行者患流感的机器学习模型

Travel Medicine and Infectious Disease
IF4.7
2026-03-060
OAAI
Yusuke Asai; Kei Yamamoto; Hidetoshi Nomoto; Hidenori Nakagawa; Toshinori Sahara; Masaya Yamato; Naoya Sakamoto; Ryota Hase; Koh Shinohara; Yukihiro Yoshimura; Atsushi Nagasaka; Takahiro Ichikawa; Natsuko Imakita; Hiroshi Miyawaki; Kyoko Yokota; Yoshihiro Yamamoto; Naoya Itoh; Nobumasa Okumura; Yusuke Yoshimi; Norio Ohmagari
Clinical characteristics, treatments and outcomes of hospitalised COVID-19 patients across pandemic waves at a tertiary acute care hospital in Narita, Japan: a single-centre retrospective observational study

尼塔市一家三级急性护理医院不同疫情波次住院COVID-19患者的临床特征、治疗及转归：一项单中心回顾性观察研究

BMJ Open
IF2.3
2026-01-080
OA
Hase, Ryota; Kurata, Rika; Niiyama, Yu; Matsuda, Naoya; Ueda, Hideki; Kikuchi, Koki; Ishida, Keiko; Kubota, Yoshifumi; Fujii, Motoki; Kurita, Takashi; Muranaka, Emiri; Sasazawa, Hiroki; Mito, Haruki; Yano, Yudai; Oku, Reiko; Tateishi, Yoshihisa; Toishi, Satoshi; Obata, Shintaro; Noguchi, Yasushi; Nakanishi, Kazuya; Sunami, Shosuke
Features of Carbapenem-resistant Gram-negative Bacterial Infections in Japan Based on the Setting of Onset

基于发病场所的日本碳青霉烯耐药革兰氏阴性菌感染特征

OPEN FORUM INFECTIOUS DISEASES
IF3.8
2025-10-010
OAAI
Kawamoto, Yuya; Asai, Yusuke; Sakurai, Aki; Matsumura, Yasufumi; Hase, Ryota; Kato, Hideaki; Matono, Takashi; Itoh, Naoya; Hashimoto, Takehiro; Yamamoto, Go; Mawatari, Momoko; Tsutsumi, Takeya; Suzuki, Tetsuya; Tsuzuki, Shinya; Ohyama, Koji; Suzuki, Masahiro; Hayakawa, Kayoko; Uemura, Kohei; van Duin, David; Ohmagari, Norio; Doi, Yohei; Saito, Sho
Molecular epidemiology and patient outcome of carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research network
JAC-ANTIMICROBIAL RESISTANCE
IF3.3
2025-03-060
OAAI
Saito, Sho; Sakurai, Aki; Matsumura, Yasufumi; Uemura, Kohei; Hase, Ryota; Kato, Hideaki; Itoh, Naoya; Hashimoto, Takehiro; Matono, Takashi; Yu, Jiefu; Hayakawa, Kayoko; Suzuki, Masahiro; Izumi, Shoki; Suzuki, Tetsuya; Kurokawa, Mari; Shinohara, Koh; Mori, Keiichiro; Endo, Yasunobu; Mito, Haruki; Sano, Kayoko; Matsunaga, Tomo; Akazawa, Nana; Hiramatsu, Kazufumi; Asai, Yusuke; Tsuzuki, Shinya; van Duin, David; Ohmagari, Norio; Doi, Yohei
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients
JOURNAL OF CLINICAL IMMUNOLOGY
IF5.7
2024-04-222
OAAI
Aoki, Ami; Iwamura, Chiaki; Kiuchi, Masahiro; Tsuji, Kaori; Sasaki, Atsushi; Hishiya, Takahisa; Hirasawa, Rui; Kokubo, Kota; Kuriyama, Sachiko; Onodera, Atsushi; Shimada, Tadanaga; Nagaoka, Tetsutaro; Ishikawa, Satoru; Kojima, Akira; Mito, Haruki; Hase, Ryota; Kasahara, Yasunori; Kuriyama, Naohide; Nakamura, Sukeyuki; Urushibara, Takashi; Kaneda, Satoru; Sakao, Seiichiro; Nishida, Osamu; Takahashi, Kazuhisa; Kimura, Motoko Y.; Motohashi, Shinichiro; Igari, Hidetoshi; Ikehara, Yuzuru; Nakajima, Hiroshi; Suzuki, Takuji; Hanaoka, Hideki; Nakada, Taka-aki; Kikuchi, Toshiaki; Nakayama, Toshinori; Yokote, Koutaro; Hirahara, Kiyoshi
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
IF9.1
2023-12-2210
OAAI
Miyamoto, Sho; Nishiyama, Takara; Ueno, Akira; Park, Hyeongki; Kanno, Takayuki; Nakamura, Naotoshi; Ozono, Seiya; Aihara, Kazuyuki; Takahashi, Kenichiro; Tsuchihashi, Yuuki; Ishikane, Masahiro; Arashiro, Takeshi; Saito, Shinji; Ainai, Akira; Hirata, Yuichiro; Iida, Shun; Katano, Harutaka; Tobiume, Minoru; Tokunaga, Kenzo; Fujimoto, Tsuguto; Suzuki, Michiyo; Nagashima, Maki; Nakagaw, Hidenori; Narita, Masashi; Kato, Yasuyuki; Igari, Hidetoshi; Fujita, Kaori; Kato, Tatsuo; Hiyama, Kazutoshi; Shindou, Keisuke; Adachi, Takuya; Fukushima, Kazuaki; Nakamura-Uchiyama, Fukumi; Hase, Ryota; Yoshimura, Yukihiro; Yamato, Masaya; Nozaki, Yasuhiro; Ohmagari, Norio; Suzuki, Motoi; Saito, Tomoya; Iwami, Shingo; Suzuki, Tadaki
Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
IF9.1
2022-07-2716
OA
Iwamura, Chiaki; Hirahara, Kiyoshi; Kiuchi, Masahiro; Ikehara, Sanae; Azuma, Kazuhiko; Shimada, Tadanaga; Kuriyama, Sachiko; Ohki, Syota; Yamamoto, Emiri; Inaba, Yosuke; Shiko, Yuki; Aoki, Ami; Kokubo, Kota; Hirasawa, Rui; Hishiya, Takahisa; Tsuji, Kaori; Nagaoka, Tetsutaro; Ishkawa, Satoru; Kojima, Akira; Mito, Haruki; Hase, Ryota; Kasahara, Yasunori; Kuriyama, Naohide; Tsukamoto, Tetsuya; Nakamura, Sukeyuki; Urushibara, Takashi; Kaneda, Satoru; Sakao, Seiichiro; Tobiume, Minoru; Suzuki, Yoshio; Tsujiwaki, Mitsuhiro; Kubo, Terufumi; Hasegawa, Tadashi; Nakase, Hiroshi; Nishida, Osamu; Takahashi, Kazuhisa; Baba, Komei; Iizumi, Yoko; Okazaki, Toshiya; Kimura, Motoko Y.; Yoshino, Ichiro; Igari, Hidetoshi; Nakajima, Hiroshi; Suzuki, Takuji; Hanaoka, Hideki; Nakada, Taka-aki; Ikehara, Yuzuru; Yokote, Koutaro; Nakayama, Toshinori
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19

新型冠状病毒肺炎住院患者早期与晚期Favipiravir治疗的前瞻性，随机，开放标签试验

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
IF4.5
2020-11-17176
OAAI
Doi, Yohei; Hibino, Masaya; Hase, Ryota; Yamamoto, Michiko; Kasamatsu, Yu; Hirose, Masahiro; Mutoh, Yoshikazu; Homma, Yoshito; Terada, Masaki; Ogawa, Taku; Kashizaki, Fumihiro; Yokoyama, Toshihiko; Koba, Hayato; Kasahara, Hideki; Yokota, Kazuhisa; Kato, Hideaki; Yoshida, Junichi; Kita, Toshiyuki; Kato, Yasuyuki; Kamio, Tadashi; Kodama, Nobuhiro; Uchida, Yujiro; Ikeda, Nobuhiro; Shinoda, Masahiro; Nakagawa, Atsushi; Nakatsumi, Hiroki; Horiguchi, Tomoya; Iwata, Mitsunaga; Matsuyama, Akifumi; Banno, Sumi; Koseki, Takenao; Teramachi, Mayumi; Miyata, Masami; Tajima, Shigeru; Maeki, Takahiro; Nakayama, Eri; Taniguchi, Satoshi; Lim, Chang Kweng; Saijo, Masayuki; Imai, Takumi; Yoshida, Hisako; Kabata, Daijiro; Shintani, Ayumi; Yuzawa, Yukio; Kondo, Masashi

研究方向

暂未获取到该数据
H
Hideaki Kato
H 指数:42论文数:351被引数:8,689
Y
Yohei Doi
H 指数:92论文数:613被引数:3.5万
K
Kayoko Hayakawa
H 指数:41论文数:366被引数:6,572
A
Aki Sakurai
H 指数:20论文数:103被引数:1,411
H
Haruki Mito
H 指数:6论文数:19被引数:163
N
Norio Ohmagari
H 指数:53论文数:821被引数:2.2万
Y
Yasufumi Matsumura
H 指数:37论文数:224被引数:4,958
T
Takashi Matono
H 指数:12论文数:86被引数:481
N
Naoya Itoh
H 指数:15论文数:120被引数:2,255
M
Masahiro Suzuki
H 指数:32论文数:273被引数:3,229